Training

Clinical Suite | Clinical Evaluation under the MDR

June 27, 2022

Date27 June 2022 

Time: 18:00 - 21:00 CEST  | 12-3 pm EST 

Location: Virtual

Price:  € 495,- / $ 550.-

Introduction:

Manufacturers struggle to address requirements for clinical evaluation for all classes of devices, with many erroneously assuming class I devices will not need clinical data. Clinical evaluation is required for all medical devices regardless of risk classification or clinical data requirements. While the ideology of evaluating clinical evidence to demonstrate compliance with relevant General Safety and Performance Requirements remains unchanged, the medical device regulation (MDR) 2017/745 along with the recently published MDCG 2020-5 Guidance on Clinical Evaluation - Equivalence and MDCG 2020-6 Guidance on Sufficient Clinical Evidence for Legacy Devices includes stringent requirements for acceptable clinical data, demonstrating equivalence to a marketed device, and the ability to establish conformity for devices in which clinical data is not deemed necessary (Article 61 section 10). 

These virtual training sessions will walk you through how to establish endpoints for clinical claims that will make identifying and assessing relevant literature and other clinical data sources more straightforward. Practical examples of devices that meet the requirements of Well-Established Technology or MDR Article 61 (10) will be provided as will common pitfalls for establishing equivalence. Manufacturers struggle to address requirements for clinical evaluation for all classes of devices, with many erroneously assuming class I devices will not need clinical data. Clinical evaluation is required for all medical devices regardless of risk classification or clinical data requirements. While the ideology of evaluating clinical evidence to demonstrate compliance with relevant General Safety and Performance Requirements remains unchanged, the medical device regulation (MDR) 2017/745 along with the recently published MDCG 2020-5 Guidance on Clinical Evaluation - Equivalence and MDCG 2020-6 Guidance on Sufficient Clinical Evidence for Legacy Devices includes stringent requirements for acceptable clinical data, demonstrating equivalence to a marketed device, and the ability to establish conformity for devices in which clinical data is not deemed necessary (Article 61 section 10). 
Jasmin Hunter
Post date: February 17, 2022
Tags
How can we help you? Contact us